Brensocatib Becomes First FDA-Approved Therapy for Bronchiectasis
Written by
American Journal Managed Care
Published
0
comments
0
min
Brensocatib (Brinsupri; Insmed) gains FDA approval as the first treatment for bronchiectasis, offering hope to patients with the chronic lung disease.